Tuesday, February 24, 2009

FDA GUIDELINES ADDRESS JOURNAL REPRINTS ON UNAPPROVED DRUG USE

The FDA has released guidelines concerning journal reprints distributed to physicians that cite the off-label use of drugs and devices. Although some welcome the guidelines as a way to help clear up the issues surrounding the practice, others say they may cause confusion about what should or should not be considered promotional.

Source: AMANews (subscription required)

No comments:

Post a Comment

Thanks for visiting.

Please be considerate... no off-topic, racist, sexist or homophobic comments.

Comment moderation is on.

No anonymous comments will be accepted..